COYA 302, an injection therapy in development for the treatment of ALS, has been awarded fast track status by the U.S. Food and Drug Administration. The therapy aims to slow ALS progression by ...

Priced at Rs 91,688 for a 350 mg vial, the prescription-only intravenous therapy is to be administered once a month for up to ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. BOSTON — A medicine increasingly used to ...

Patients — and their doctors — have been desperate for a more effective pancreatic cancer treatment for decades. Now one ...

A new class of drugs is saving the lives of children who once had no hope. These high-tech medicines can replace defective genes. But there's a catch. Many cost millions of dollars for a single dose.

On March 20, the FDA approved Opdivo for adult and pediatric patients (aged 12 years and older) with previously untreated stage III or IV classical Hodgkin lymphoma when used in combination with ...

Medications are designed to treat diseased tissues while sparing healthy ones, often by attaching the drug to something that helps guide it directly to its target. But drugs also need time to work, ...

A UAB clinical trial published in JAMA Network Open finds that psilocybin, combined with therapy, shows promise as a safe and ...

Doctors in Sacramento are using transcranial magnetic stimulation and experimental drugs inspired by psychedelics to address ...

The U.S. Food and Drug Administration is reviewing a new Parkinson’s disease drug called tavapadon that could give people with the disease more control over their movements. If approved, it would be ...